retail shorts estimated around 7-10 mil.
Can't agree more. Tutes have all the tools to hedge and definitely hear it first than retail shorts. I think i would be worried a lot if i am retail short....
Better than any medication.
Here is an example that FDA approves acute use first then based on long term study to approve long term use later:
US FDA approves expanded indication for BRILINTA to include long-term use in patients with a history of heart attack
Thursday, 3 September 2015
I find this particular study is interesting:
NCT02607085 is to evaluate patients with Standard of Care when admitted to the Emergency room with hyperkalemia. Stardard of care includes all the current treatments: intravenous [IV] calcium, insulin/glucose, beta2-agonists, diuretics, IV bicarbonate, sodium polystyrene sulfonate (Kayexalate), dialysis and/or other intervention.
No zs-9 involved in this study. looks like FDA wants to compare zs-9 to all the current acute treatments.
Once again it reinforces my belief -- zs-9 is seeking acute use only in May, 2016. Even that this baseline data won't be available for May PDUFA. Very high chance to delay.
down a fraction from 1/15. This is in my expectation. Not much downside and few new short shares to lend... I bet a small & smart shorts are covering daily... I assume you will see more short covering close to ER GLTA!
I believe they have payments from euro partner. Also expense should exclude stock option since it is non cash item. They have a lot clinical trials last year and some this year. Will they continue to have clinical trials? This could reduce burn rate a lot!
Even cash is needed. I don't think it will be a lot since no clinical trial in 2017. Convert Bond or new loan can also do the trick.
There are 40 mil upfront payment. I think some is paid in 2015. Probably 25-30 mil will be paid in 2016. Stock option probably 15-20 mil. so you have 40-50 mil more. 125 milestone payment probably will get it in 2017, I think SO is not necessary. Remember they have little debt now. They can open debt facility if they need cash.